why choose us

300×250 Ad Slot

Research Article: Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: -Month Results from the SUPREME . Study

Date Published: 2023-12-12

Introduction:
Psoriasis (PsO) is a chronic immune-mediated inflammatory multifactorial disease with a genetic predisposition and environmental triggers. The most prevalent and well-recognised morphological presentation of PsO is the chronic plaque-type, which is characterised by accelerated keratinocyte proliferation and hyperplasia of the epidermis resulting in the development of well-demarcated, erythematous, infiltrated and scaly plaques. –

Read more

300×250 Ad Slot